Holen Sie sich die Stockscreener-App
1.54
0.01%
0.01
Handel nachbörslich:
1.54
Schlusskurs vom Vortag:
$1.53
Offen:
$1.545
24-Stunden-Volumen:
612.88K
Relative Volume:
0.58
Marktkapitalisierung:
$20.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.51M
KGV:
-1.1667
EPS:
-1.32
Netto-Cashflow:
$-8.02M
1W Leistung:
+0.01%
1M Leistung:
-4.37%
6M Leistung:
+85.44%
1J Leistung:
+86.60%
1-Tages-Spanne:
$1.45
$1.57
1-Wochen-Bereich:
$1.45
$1.78
52-Wochen-Spanne:
$0.6554
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Firmenname
Hoth Therapeutics Inc
Sektor
Branche
Telefon
(646)756-2997
Adresse
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Vergleichen Sie HOTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.54 | 20.29M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-10-15 | Eingeleitet | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten
Measuring Hoth Therapeutics Inc.’s beta against major indicesMarket Movement Recap & Daily Profit Focused Stock Screening - newser.com
Should you wait for a breakout in Hoth Therapeutics Inc.Jobs Report & Daily Entry Point Trade Alerts - newser.com
How to forecast Hoth Therapeutics Inc. trends using time seriesTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com
Can momentum traders help lift Hoth Therapeutics Inc.Quarterly Performance Summary & Verified Chart Pattern Trade Signals - newser.com
Why hedge funds are buying Hoth Therapeutics Inc. stockJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com
Chart based analysis of Hoth Therapeutics Inc. trendsEntry Point & Smart Investment Allocation Insights - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyStop Loss & Free Weekly Watchlist of Top Performers - newser.com
What candlestick patterns are forming on Hoth Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Is Hoth Therapeutics Inc. stock entering bullish territoryJuly 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
What valuation multiples suggest for Hoth Therapeutics Inc. stockMarket Movers & Fast Entry Momentum Trade Alerts - newser.com
What analysts say about Hoth Therapeutics Inc stockSector ETF Performance & Free High Yield Growth Strategies - earlytimes.in
Hoth Therapeutics shares climb after expanding AI partnership with NVIDIA - MSN
Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA By Investing.com - Investing.com Nigeria
Hoth Therapeutics stock rises after expanding AI initiative with NVIDIA - Investing.com
Hoth Therapeutics rises as it expands AI push with Nvidia licenses - TradingView
Hoth Therapeutics expands AI capabilities with NVIDIA partnership By Investing.com - Investing.com Canada
Hoth Therapeutics expands artificial intelligence initiative, selects NVIDIA AI Enterprise platform - MarketScreener
Hoth Therapeutics expands AI capabilities with NVIDIA partnership - Investing.com
Hoth Therapeutics Expands Artificial Intelligence Initiative, Selects NVIDIA AI Enterprise Platform - MarketScreener
Hoth Therapeutics CEO Robb Knie to Present at BIO-Europe in Vienna, Austria November 3-5, 2025 - WV News
Analyzing Hoth Therapeutics Inc. with multi timeframe chartsVolume Spike & Community Verified Swing Trade Signals - newser.com
Best data tools to analyze Hoth Therapeutics Inc. stock2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Hoth Therapeutics Announces Pipeline Presentation at the 2022 BIO International Convention - ADVFN
EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Epidemiology, Regulations, Pipeline Analysis Featuring Azitra, Hoth Therapeutics, and Lutris PharmaResearchAndMarkets.com - The AI Journal
About Us - FinancialContent
Is Hoth Therapeutics Inc a good long term investmentCandlestick Pattern Analysis & Free Exceptional Risk Adjusted Gains - earlytimes.in
What institutional flow reveals about Hoth Therapeutics Inc.Portfolio Value Summary & High Yield Stock Recommendations - newser.com
EGFR Inhibitors-Induced Skin Disorders Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lutris Pharma, Hoth Therapeutics, TWi Biotechnology - Barchart.com
Hoth expands HT-001 development with patents for cancer therapy side effects - Investing.com Nigeria
Hoth expands HT-001 development with patents for cancer therapy side effects By Investing.com - Investing.com South Africa
Hoth Therapeutics Expands Patent Portfolio for HT-001 to Target Wider Range of Skin Toxicities - MarketScreener
Hoth Therapeutics Expands HT-001 Development with Patent Filings Targeting Drug-Induced Hypersensitivity, Radiotherapy-Induced Rash, and MENIN Inhibitor-Associated Skin Toxicities - WV News
Hoth Therapeutics, Inc. (HOTH) Files EMA Application for Global Expansion of HT-001 Skin Therapy - Yahoo Finance
Finanzdaten der Hoth Therapeutics Inc-Aktie (HOTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):